Rick has over 35 years of experience in biotechnology management where he has built global marketing and sales campaigns, structured and executed large contracts, licensing, partnerships, brought in significant venture investment, and taken companies through acquisition. Rick is crucial for Tempo’s business development strategy and corporate operations.
Dino Di Carlo, PhD
Dino is a co-founder and co-inventor of Tempo's technology, He is the vice-chair of Bioengineering at UCLA, with 100+ peer reviewed journal articles and 20+ patents. He is also an experienced biotechnology entrepreneur, with two venture-backed companies. Dino plays a critical role in Tempo's early development.
Steven Richieri, MBA
Steve has over 30 years of experience in the biotechnology and medical device arena. He has founded 4 successful companies where he served various executive roles including CEO and COO. He has regulatory experience, with 22 approved FDA submissions including 510(k), De Novo, and PMA mechanisms. Steve helps direct Tempo’s business development and regulatory execution.